Cited by 362Ovarian function and disordersDiabetes, Cardiovascular Risks, and LipoproteinsGenetic and Kidney Cyst Diseases

The DOI matches its Crossref record; 110 of the 113 references it cites were found in a registry or an index.

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Moran, Lisa, Teede, Helena·2009·Human Reproduction Update

DOI 10.1093/humupd/dmp008

Open this paper in CoChat — free account

Abstract

BACKGROUND Polycystic ovary syndrome (PCOS) is a common condition in women of reproductive age with well established metabolic abnormalities. There are numerous diagnostic criteria generating several reproductive diagnostic phenotypes [National Institute of Health (NIH) hyperandrogenic anovulatory PCOS and non-NIH PCOS including hyperandrogenic ovulatory or non-hyperandrogenic anovulatory PCOS]. There is ongoing debate regarding the optimal diagnostic criteria for PCOS and on the metabolic implications of newer non-NIH PCOS phenotypes. METHODS We reviewed the literature on the presence of risk factors for type 2 diabetes (DM2) and cardiovascular disease (CVD) across the reproductive diagnostic phenotypes of PCOS with the aims of comparing the metabolic features of the NIH and non-NIH groups and identifying potential high metabolic risk phenotypes of PCOS. RESULTS NIH PCOS patients present with greater obesity, abdominal obesity, insulin resistance (IR) and risk factors for DM2 and CVD compared with non-NIH ovulatory and non-hyperandrogenic PCOS patients. Where differences in metabolic features exist between the phenotypes, they are generally related to the degree of total and abdominal obesity. There is emerging evidence suggesting ovulatory and non-hyperandrogenic PCOS have greater metabolic abnormalities than controls primarily linked to abdominal adiposity. There is currently no evidence that non-hyperandrogenic PCOS is associated with a less adverse metabolic profile than ovulatory PCOS. CONCLUSIONS Current metabolic evidence appears to justify the inclusion of both non-NIH PCOS groups (ovulatory and non-hyperandrogenic) as PCOS subgroups. NIH PCOS is associated with a more adverse metabolic profile including greater total and abdominal obesity, IR and risk factors for CVD and DM2 than non-NIH phenotypes.

Integrity signals

Registry

Crossref · 10.1093/humupd/dmp008

Cites

110 of 110 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

1 retracted

Withdrawn: Postmenopausal Women with a History of Irregular Menses and Elevated Androgen Measurements at High Risk for Worsening Cardiovascular Event-Free Survival: Results from the National Institutes of Health—National Heart, Lung, and Blood Institute Sponsored Women’s Ischemia Syndrome Evaluation
Shaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
Retracted
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138
A Critical Evaluation of Simple Methods for the Estimation of Free Testosterone in Serum
Vermeulen, A., Verdonck, L., & Kaufman, J. M. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.10.6079 · Cited by 3,824
The Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yıldız, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,715
Clinical assessment of body hair growth in women.
Ferriman, D., & Gallwey, J. D. (1961) · Journal of Clinical Endocrinology and Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,556
Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Prevalence of the Polycystic Ovary Syndrome in Unselected Black and White Women of the Southeastern United States: A Prospective Study
Knochenhauer, E. S., Key, T. J., Kahsar-Miller, M., Waggoner, W., Boots, L. R., & Azziz, R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.9.5090 · Cited by 1,759
Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women
Legro, R. S. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.1.165 · Cited by 1,743

Show all 113 references

Sorted by citations

Items 101–200 of 361

Ultrasound Characterization of Disordered Antral Follicle Development in Women with Polycystic Ovary Syndrome
Jarrett, B. Y., Brink, H. V., Oldfield, A. L., & Lujan, M. E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa515 · Cited by 46
Symptom patterns and phenotypic subgrouping of women with polycystic ovary syndrome: association between endocrine characteristics and metabolic aberrations
Huang, C., Tien, Y.-J., Chen, M., Chen, C., Ho, H., & Yang, Y. (2015) · Human Reproduction · doi:10.1093/humrep/dev010 · Cited by 45
Gene expression in subcutaneous adipose tissue differs in women with polycystic ovary syndrome and controls matched pair-wise for age, body weight, and body mass index
Mannerås-Holm, L., Benrick, A., & Stener‐Victorin, E. (2014) · Adipocyte · doi:10.4161/adip.28731 · Cited by 43
Rhamnocitrin Attenuates Ovarian Fibrosis in Rats with Letrozole‐Induced Experimental Polycystic Ovary Syndrome
Zhou, Y., Lan, H., Dong, Z., Li, W., Qian, B., Zeng, Z., He, W., & Song, J. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/5558599 · Cited by 44
Luteinizing hormone/chorionic gonadotrophin receptor overexpressed in granulosa cells from polycystic ovary syndrome ovaries is functionally active
Kanamarlapudi, V., Gordon, U. D., & López Bernal, A. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.03.003 · Cited by 44
The Frequency of Metabolic Syndrome is Higher Among PCOS Brazilian Women With Menstrual Irregularity Plus Hyperandrogenism
de Melo, A. S., Vieira, C. S., Romano, L. G. M., Ferriani, R. A., & Navarro, P. A. (2011) · Reproductive Sciences · doi:10.1177/1933719111414205 · Cited by 43
Insulin resistance and the long-term consequences of polycystic ovary syndrome
Bhathena, R. K. (2011) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443615.2010.539722 · Cited by 44
Association between Th1/Th2 immune imbalance and obesity in women with or without polycystic ovary syndrome
Gong, P., Shi, B., Wang, J., Cao, P., Diao, Z., Wang, Y., Hu, Y., & Li, S. (2018) · Gynecological Endocrinology · doi:10.1080/09513590.2018.1428301 · Cited by 43
Metabolic profile of the different phenotypes of polycystic ovary syndrome in two Latin American populations
de Guevara, A. L., Otta, C. F., Crisosto, N., de Mereshian, P. S., Echiburú, B., Iraci, G. S., Pérez‐Bravo, F., & Sir‐Petermann, T. (2014) · Fertility and Sterility · doi:10.1016/j.fertnstert.2014.02.020 · Cited by 44
Diabetes risk score in the diagnostic categories of polycystic ovary syndrome
Moran, L. J., Strauss, B. J., & Teede, H. J. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2011.01.133 · Cited by 41
Self-citation
Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome
Shim, U., Kim, H.-N., Lee, H., Oh, J.-Y., 성연아, & Kim, H.-L. (2015) · PLoS ONE · doi:10.1371/journal.pone.0136609 · Cited by 42
Lipid accumulation product and insulin resistance in Iranian PCOS prevalence study
Hosseinpanah, F., Barzin, M., Erfani, H., Serahati, S., Tehrani, F. R., & Azizi, F. (2013) · Clinical Endocrinology · doi:10.1111/cen.12287 · Cited by 40
Genetic Markers of Polycystic Ovary Syndrome: Emphasis on Insulin Resistance
Shaikh, N. J., Dadachanji, R., & Mukherjee, S. (2014) · International Journal of Medical Genetics · doi:10.1155/2014/478972 · Cited by 44
Influence of race/ethnicity on cardiovascular risk factors in polycystic ovary syndrome, the Dallas Heart Study
Chang, A. Y., Oshiro, J., Ayers, C. R., & Auchus, R. J. (2015) · Clinical Endocrinology · doi:10.1111/cen.12986 · Cited by 40
Improvements in PCOS characteristics and phenotype severity during a randomized controlled lifestyle intervention
Dietz de Loos, A. L. P., Jiskoot, G., Timman, R., Beerthuizen, A., Busschbach, J. J. V., & Laven, J. S. E. (2021) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2021.05.008 · Cited by 39
Comparison of serum anti-Müllerian hormone levels in normal weight and overweight–obese adolescent patients with polycystic ovary syndrome
Cengiz, H., Ekin, M., Dağdeviren, H., Yıldız, Ş., Kaya, C., & Kanawati, A. (2014) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2014.06.018 · Cited by 39
Hormonal contraceptive choice for women with PCOS: a systematic review of randomized trials and observational studies
Mendoza, N., Simoncini, T., & Genazzani, A. D. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.943725 · Cited by 38
Vascular function in the diagnostic categories of polycystic ovary syndrome
Moran, L., Cameron, J. D., Strauss, B. J., & Teede, H. J. (2011) · Human Reproduction · doi:10.1093/humrep/der159 · Cited by 36
Self-citation
Early and late pregnancy loss in women with polycystic ovary syndrome undergoing IVF/ICSI treatment: a retrospective cohort analysis of 21 820 pregnancies
Cai, H., Mol, B. W., Gordts, S., Wang, H., Wang, T., Li, N., & Shi, J. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16590 · Cited by 36
The association between hyperandrogenemia and the metabolic syndrome in morbidly obese women
Valderhaug, T. G., Hertel, J. K., Nordstrand, N., Dale, P. O., Hofsø, D., & Hjelmesaeth, J. S. (2015) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-015-0040-5 · Cited by 35
Higher Metabolic Risk with National Institutes of Health Versus Rotterdam Diagnostic Criteria for Polycystic Ovarian Syndrome in Turkish Women
Anaforoğlu, İ., Algün, E., İnceçayır, Ö., & Ersoy, K. (2011) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2011.0019 · Cited by 35
Elucidating the impact of obesity on hormonal and metabolic perturbations in polycystic ovary syndrome phenotypes in Indian women
Dadachanji, R., Patil, A. D., Joshi, B. N., & Mukherjee, S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246862 · Cited by 34
The lack of association between polycystic ovary syndrome and metabolic syndrome: Iranian PCOS prevalence study
Hosseinpanah, F., Barzin, M., Tehrani, F. R., & Azizi, F. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04113.x · Cited by 34
Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study
Hosseinpanah, F., Barzin, M., Keihani, S., Tehrani, F. R., & Azizi, F. (2014) · Clinical Endocrinology · doi:10.1111/cen.12406 · Cited by 34
Metabolic Syndrome in Patients with Polycystic Ovary Syndrome in Iran.
Zahiri, Z., Sharami, S. H., Milani, F., Mohammadi, F., Kazemnejad, E., Ebrahimi, H., & Heirati, S. F. D. (2016) · Europe PMC (PubMed Central) · doi:10.22074/ijfs.2015.4607 · Cited by 36
Ovarian morphology is associated with insulin resistance in women with polycystic ovary syndrome: a cross sectional study
Pittenger, S. R., Kao, C., Pasch, L. A., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2017) · Fertility Research and Practice · doi:10.1186/s40738-017-0035-z · Cited by 33
Obesity and polycystic ovary syndrome: association with androgens, leptin and its genotypes
Pusalkar, M., Meherji, P. K., Gokral, J., Savardekar, L., Chinnaraj, S., & Maitra, A. (2010) · Gynecological Endocrinology · doi:10.3109/09513590.2010.487586 · Cited by 33
Effects of vitamin D supplementation on follicular development, gonadotropins and sex hormone concentrations, and insulin resistance in induced polycystic ovary syndrome
Behmanesh, N., Abedelahi, A., Charoudeh, H. N., & Alihemmati, A. (2019) · Journal of Turkish Society of Obstetric and Gynecology · doi:10.4274/tjod.galenos.2019.46244 · Cited by 32
Adipocyte Dysfunction in a Mouse Model of Polycystic Ovary Syndrome (PCOS): Evidence of Adipocyte Hypertrophy and Tissue-Specific Inflammation
Marino, J. S., Iler, J., Dowling, A. R., Chua, S. C., Brüning, J. C., Coppari, R., & Hill, J. W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048643 · Cited by 31
Health related quality of life and psychological parameters in different polycystic ovary syndrome phenotypes: a comparative cross-sectional study
Bahadori, F., Sadatmahalleh, S. J., & Mirzaei, N. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00811-2 · Cited by 36
Genetic variants associated with insulin signaling and glucose homeostasis in the pathogenesis of insulin resistance in polycystic ovary syndrome: a systematic review
Bhaskar, L. V., Thangavelu, M., & Rani, G. U. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0030-1 · Cited by 32
Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity
Chiu, W.-L., Boyle, J. A., Vincent, A. J., Teede, H. J., & Moran, L. (2016) · Neuroendocrinology · doi:10.1159/000455233 · Cited by 31
Self-citation
Efficacy of Salvia officinalis extract on the prevention of insulin resistance in euglycemic patients with polycystic ovary syndrome: A double-blinded placebo-controlled clinical trial
Amini, L., Mojab, F., Jahanfar, S., Sepidarkish, M., Raoofi, Z., & Maleki-Hajiagha, A. (2020) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.102245 · Cited by 30
Dehydroepiandrosterone-induced polycystic ovary syndrome mouse model requires continous treatments to maintain reproductive phenotypes
Wu, H., Zhao, B., Yao, Q., & Kang, J. (2023) · Journal of Ovarian Research · doi:10.1186/s13048-023-01299-8 · Cited by 30
Mice endometrium receptivity in early pregnancy is impaired by maternal hyperinsulinemia
Li, R., Wu, J., He, J., Wang, Y., Liu, X., Chen, X., Tong, C., Ding, Y., Su, Y., Chen, W., et al. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6322 · Cited by 30
Effects of Synbiotic Supplementation and Lifestyle Modifications on Women With Polycystic Ovary Syndrome
Chudzicka-Strugała, I., Kubiak, A., Banaszewska, B., Zwoździak, B., Siakowska, M., Pawelczyk, L. A., & Dulęba, A. J. (2021) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgab369 · Cited by 32
Investigation of common risk factors between polycystic ovary syndrome and Alzheimer’s disease: a narrative review
Sarahian, N., Sarvazad, H., Sajadi, E., Rahnejat, N., & Eskandari Roozbahani, N. (2021) · Reproductive Health · doi:10.1186/s12978-021-01203-x · Cited by 30
Effects of Upregulation of Hsp27 Expression on Oocyte Development and Maturation Derived from Polycystic Ovary Syndrome
Cai, L., Ma, X., Liu, S., Liu, J., Wang, W. T., Cui, Y., Ding, W., Mao, Y., Chen, H., Huang, J., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0083402 · Cited by 30
Association of circulating monocyte chemoattractant protein‐1 levels with polycystic ovary syndrome: A meta‐analysis
Wu, Z., Fang, L., Li, Y., Yan, Y., Thakur, A., Cheng, J., & Sun, Y. (2021) · American Journal of Reproductive Immunology · doi:10.1111/aji.13407 · Cited by 29
Polycystic ovary syndrome – Phenotypes and diagnosis
Christakou, C. D., & Diamanti‐Kandarakis, E. (2014) · Scandinavian Journal of Clinical and Laboratory Investigation · doi:10.3109/00365513.2014.936675 · Cited by 29
Impact of hypocaloric dietary intervention on ovulation in obese women with PCOS
Jarrett, B. Y., & Lujan, M. E. (2016) · Reproduction · doi:10.1530/rep-16-0385 · Cited by 29
Barriers and Facilitators to Weight and Lifestyle Management in Women with Polycystic Ovary Syndrome: General Practitioners’ Perspectives
Arasu, A., Moran, L., Robinson, T., Boyle, J. A., & Lim, S. S. (2019) · Nutrients · doi:10.3390/nu11051024 · Cited by 29
Self-citation
Polycystic ovary syndrome: Criteria, phenotypes, race and ethnicity
Baba, T. (2025) · Reproductive Medicine and Biology · doi:10.1002/rmb2.12630 · Cited by 34
Different phenotypes of polycystic ovary syndrome in Turkish women: clinical and endocrine characteristics
Ateş, S., Şevket, O., Sudolmuş, S., Dane, B., Özkal, F., Uysal, Ö., & Dansuk, R. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2013.819082 · Cited by 28
Cardiovascular risk factors in polycystic ovary syndrome
Karaer, A., Cavkaytar, S., Mert, İ., Buyukkagnici, U., & Batıoğlu, S. (2010) · Journal of Obstetrics and Gynaecology · doi:10.3109/01443611003763408 · Cited by 28
Sex Steroid Hormones and Reproductive Disorders
Fauser, B. C. J. M., Laven, J. S. E., Tarlatzis, B. C., Moley, K. H., Critchley, H., Taylor, R. N., Berga, S. L., Mermelstein, P. G., Devroey, P., Gianaroli, L., et al. (2011) · Reproductive Sciences · doi:10.1177/1933719111405068 · Cited by 30
The Hirsute Woman: Challenges in Evaluation and Management
Paparodis, R. D., & Dunaif, A. E. (2011) · Endocrine Practice · doi:10.4158/ep11117.ra · Cited by 27
Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels
Koiou, E., Τζιόμαλος, Κ., Katsikis, I., Kalaitzakis, E., Kandaraki, E., Tsourdi, E. A., Delkos, D., Papadakis, E. P., & Panidis, D. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0144 · Cited by 27
Fasting glucose measurement as a potential first step screening for glucose metabolism abnormalities in women with anovulatory polycystic ovary syndrome
Veltman-Verhulst, S. M., Goverde, A. J., van Haeften, T. W., & Fauser, B. C. J. M. (2013) · Human Reproduction · doi:10.1093/humrep/det226 · Cited by 25
Effects of Drospirenone–Ethinylestradiol and/or Metformin on CD4+CD28null T Lymphocytes Frequency in Women With Hyperinsulinemia Having Polycystic Ovary Syndrome: A Randomized Clinical Trial
Moro, F., Morciano, A., Tropea, A., Sagnella, F., Palla, C., Scarinci, E., Ciardulli, A., Martínez, D., Familiari, A., Liuzzo, G., et al. (2013) · Reproductive Sciences · doi:10.1177/1933719113488444 · Cited by 26
Metabolic characteristics of normal weight central obesity phenotype polycystic ovary syndrome women: a large-scale national epidemiological survey
Mu, L., Zhao, Y., Li, R., Lai, Y.-C., & Qiao, J. (2018) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2018.08.007 · Cited by 25
Effects of apolipoprotein E genotypes on metabolic profile and oxidative stress in south-west Chinese women with polycystic ovary syndrome
Liu, H., Zhang, F., Fan, P., Bai, H., Zhang, J., & Wang, Y. (2013) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2013.04.016 · Cited by 24
Prevalence of metabolic syndrome in reproductive-aged polycystic ovary syndrome Thai women.
Indhavivadhana, S., Wongwananuruk, T., Rattanachaiyanont, M., Techatraisak, K., Leerasiri, P., Tanmahasamut, P., & Popijan, M. (2010) · PubMed · Cited by 24
To Assess the Association between Glucose Metabolism and Ectopic Lipid Content in Different Clinical Classifications of PCOS
Göbl, C. S., Ott, J., Bozkurt, L., Feichtinger, M., Rehmann, V., Cserjan, A., Heinisch, M., Steinbrecher, H., Kukurová, I. J., Klepochová, R., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0160571 · Cited by 24
Polycystic ovary syndrome and metabolic syndrome in Indigenous Australian women
Boyle, J. A., Cunningham, J., Norman, R. J., Dunbar, T., & O’Dea, K. (2015) · Internal Medicine Journal · doi:10.1111/imj.12910 · Cited by 23
Clomiphene Citrate co-treatment with low dose urinary FSH versus urinary FSH for clomiphene resistant PCOS: randomized controlled trial
Ghanem, M. E., Elboghdady, L. A., Hassan, M. H., Helal, A. S., Gibreel, A., Houssen, M. E., Shaker, M. E., Bahlol, I., & Mesbah, Y. (2013) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-013-0090-2 · Cited by 22
Co-Administration of Metformin and N-Acetyl Cysteine Fails to Improve Clinical Manifestations in PCOS Individual Undergoing ICSI.
Cheraghi, E., Mehranjani, M. S., Shariaatzadeh, M. A., Esfahani, M. H. N., & Ebrahimi, Z. (2014) · PubMed · Cited by 22
Prediabetes and diabetes in a cohort of Qatari women screened for polycystic ovary syndrome
Dargham, S. R., Elshewehy, A. M. M., Dakroury, Y., Kilpatrick, E. S., & Atkin, S. L. (2018) · Scientific Reports · doi:10.1038/s41598-018-21987-6 · Cited by 21
Sexuality and psychological well-being in different polycystic ovary syndrome phenotypes compared with healthy controls: a cross-sectional study
Bahadori, F., Sadatmahalleh, S. J., Montazeri, A., & Nasiri, M. (2022) · BMC Women s Health · doi:10.1186/s12905-022-01983-9 · Cited by 28
Metformin and exenatide upregulate hepatocyte nuclear factor-4α, sex hormone binding globulin levels and improve hepatic triglyceride deposition in polycystic ovary syndrome with insulin resistance rats
Xing, C., Lv, B., Zhao, H., Wang, D., Li, X., & He, B. (2021) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2021.105992 · Cited by 21
Cholesterol, endocrine and metabolic disturbances in sporadic anovulatory women with regular menstruation
Mumford, S. L., Schisterman, E. F., Siega‐Riz, A. M., Gaskins, A. J., Steiner, A. Z., Daniels, J. L., Olshan, A. F., Hediger, M. L., Hovey, K. M. O., Wactawski‐Wende, J., et al. (2010) · Human Reproduction · doi:10.1093/humrep/deq322 · Cited by 21
Cabergoline plus metformin therapy effects on menstrual irregularity and androgen system in polycystic ovary syndrome women with hyperprolactinemia.
Ghaneei, A., Jowkar, A., Ghavam, M. R. H., & Ghaneei, M. E. (2015) · Europe PMC (PubMed Central) · Cited by 19
Weight Management Strategies to Reduce Metabolic Morbidity in Women With Polycystic Ovary Syndrome
Diakosavvas, M., Oyebode, O. O., & Bhide, P. (2025) · Current Obesity Reports · doi:10.1007/s13679-025-00614-2 · Cited by 19
Concentração dos hormônios esteroides no fluido folicular de folículos ovarianos maduros e imaturos de pacientes com síndrome dos ovários policísticos submetidas à fertilização in vitro
de Resende, L. O. T., dos Reis, R. M., Ferriani, R. A., Vireque, A. A., Santana, L. F., Silva, A. C. J. D. S. R. E., & Martins, W. P. (2010) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032010000900006 · Cited by 19
Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
Quinn, M. M., Kao, C., Ahmad, A., Lenhart, N. J., Shinkai, K., Cedars, M. I., & Huddleston, H. G. (2016) · Fertility and Sterility · doi:10.1016/j.fertnstert.2016.06.026 · Cited by 20
Interrupting Prolonged Sitting and Endothelial Function in Polycystic Ovary Syndrome
Taylor, F., Dunstan, D. W., Fletcher, E. A., Townsend, M. K., Larsen, R. N., Rickards, K., Maniar, N., Buman, M. P., Dempsey, P. C., Joham, A. E., et al. (2020) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000002513 · Cited by 19
Self-citation
Serum Anti-Müllerian Hormone Levels Were Negatively Associated With Body Fat Percentage in PCOS Patients
Luo, E., Zhang, J., Song, J., Feng, D., Meng, Y., Jiang, H., Li, D., & Fang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.659717 · Cited by 19
CD4+CD28null T lymphocyte frequency, a new marker of cardiovascular risk: relationship with polycystic ovary syndrome phenotypes
Moro, F., Morciano, A., Tropea, A., Sagnella, F., Palla, C., Scarinci, E., Cosentino, N., Niccoli, G., Liuzzo, G., Crea, F., et al. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.08.015 · Cited by 19
How does acupuncture affect insulin sensitivity in women with polycystic ovary syndrome and insulin resistance? Study protocol of a prospective pilot study
Zheng, Y., Stener‐Victorin, E., Ng, E. H. Y., Li, J., Wu, X., & Ma, H. (2015) · BMJ Open · doi:10.1136/bmjopen-2015-007757 · Cited by 19
INSULIN RESISTANCE AND POLYCYSTIC OVARY SYNDROME
Sonagara, V., Mor, P., & Rathore, A. K. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/7602396 · Cited by 19
Efficient derivation of Chinese human embryonic stem cell lines from frozen embryos
Li, C., Yang, Y., Lu, X., Sun, Y., Gu, J., Feng, Y., & Jin, Y. (2010) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-010-9304-4 · Cited by 18
Adiposity is associated with anovulation independent of serum free testosterone: A prospective cohort study
Bloom, M. S., Perkins, N. J., Sjaarda, L. A., Mumford, S. L., Ye, A., Kim, K., Kuhr, D. L., Nobles, C. J., Connell, M. T., & Schisterman, E. F. (2020) · Paediatric and Perinatal Epidemiology · doi:10.1111/ppe.12726 · Cited by 21
Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome
Koiou, E., Τζιόμαλος, Κ., Dinas, K. D., Katsikis, I., Kandaraki, E., Tsourdi, E. A., Mavridis, S., & Panidis, D. (2011) · Endocrine Journal · doi:10.1507/endocrj.ej11-0023 · Cited by 18
Gestational Diabetes Mellitus and Metabolic Disorder Among the Different Phenotypes of Polycystic Ovary Syndrome
Ashrafi, M., Sheikhan, F., Arabipoor, A., Rouhana, N. A., Hosseini, R., & Zolfaghari, Z. (2017) · Oman Medical Journal · doi:10.5001/omj.2017.40 · Cited by 18
The Phenotypes of Polycystic Ovary Syndrome Defined by the 1990 Diagnostic Criteria Are Associated with Higher Serum Vaspin Levels than the Phenotypes Introduced by the 2003 Criteria
Koiou, E., Dinas, K. D., Τζιόμαλος, Κ., Toulis, K. A., Kandaraki, E., Kalaitzakis, E., Katsikis, I., & Panidis, D. (2011) · Obesity Facts · doi:10.1159/000327935 · Cited by 18
Emodin improves glucose metabolism and ovarian function in PCOS mice via the HMGB1/TLR4/NF-κB molecular pathway
Otoo, A., Czika, A., Lamptey, J., Yang, J.-P., Feng, Q., Wang, M., Wang, Y., & Ding, Y. (2023) · Reproduction · doi:10.1530/rep-22-0449 · Cited by 17
Coexistence of asthma and polycystic ovary syndrome: A concise review
Zierau, L., Gade, E. J., Lindenberg, S., Backer, V., & Thomsen, S. F. (2016) · Respiratory Medicine · doi:10.1016/j.rmed.2016.08.025 · Cited by 17
Excess Metabolic and Cardiovascular Risk is not Manifested in all Phenotypes of Polycystic Ovary Syndrome: Implications for Diagnosis and Treatment
Daskalopoulos, G. N., Karkanaki, A., Piouka, A., Πράπας, Ν., Panidis, D., Gkeleris, P., & Athyros, V. G. (2015) · Current Vascular Pharmacology · doi:10.2174/1567201812666150120163025 · Cited by 17
Clinical and metabolic characteristics of Turkish adolescents with polycystic ovary syndrome
Ateş, S., Aydın, S., Özcan, P., Soyman, Z., Karasu, A. F. G., & Şevket, O. (2017) · Journal of Obstetrics and Gynaecology · doi:10.1080/01443615.2017.1345875 · Cited by 17
POLYCYSTIC OVARY SYNDROME: ORIGINS AND IMPLICATIONS: Polycystic ovary syndrome: the impact of androgen excess on metabolic health
Cussen, L., McDonnell, T., Miller, C., McIlroy, M., & O’Reilly, M. (2025) · Reproduction · doi:10.1530/rep-25-0102 · Cited by 19
Barriers and facilitators to the implementation of lifestyle management in polycystic ovary syndrome: Endocrinologists’ and obstetricians and gynaecologists’ perspectives
Chhour, I., Blackshaw, L., Moran, L., Boyle, J. A., Robinson, T., & Lim, S. S. (2021) · Patient Education and Counseling · doi:10.1016/j.pec.2021.12.013 · Cited by 16
Self-citation
MiR-let-7d-3p inhibits granulosa cell proliferation by targeting TLR4 in polycystic ovary syndrome
Wu, W., Duan, C., Lv, H., Song, J., Cai, W.-Y., Fu, K., & Xu, J. (2021) · Reproductive Toxicology · doi:10.1016/j.reprotox.2021.10.003 · Cited by 16
Editorial commentary: What's in a number? The polycystic ovary revisited
Raine‐Fenning, N. J. (2011) · Human Reproduction · doi:10.1093/humrep/der300 · Cited by 16
Statins for women with polycystic ovary syndrome not actively trying to conceive
Raval, A. D., Hunter, T., Stuckey, B. G. A., & Hart, R. J. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008565 · Cited by 16
Longitudinal prospective cohort study evaluating prognosis in idiopathic intracranial hypertension patients with and without comorbid polycystic ovarian syndrome
Thaller, M., Homer, V., Sassani, M., Mollan, S. P., & Sinclair, A. J. (2023) · Eye · doi:10.1038/s41433-023-02569-x · Cited by 17
Health-related quality of life in women with newly diagnosed polycystic ovary syndrome randomized between clomifene citrate plus metformin or clomifene citrate plus placebo
Moll, E., van Wely, M., Lambalk, C. B., Bossuyt, P. M., & van der Veen, F. (2012) · Human Reproduction · doi:10.1093/humrep/des310 · Cited by 16
Association of heme oxygenase-1 with the risk of polycystic ovary syndrome in non-obese women
Gao, H. Y., Meng, J., Xing, H., Nie, S., Xu, M., Zhang, S., Jin, Y., Sun, T., Huang, H., Zhang, H., et al. (2014) · Human Reproduction · doi:10.1093/humrep/deu029 · Cited by 15
Metabolic comparison of polycystic ovarian syndrome and control women in Middle Eastern and UK Caucasian populations
Butler, A. E., Abouseif, A., Dargham, S. R., Sathyapalan, T., & Atkin, S. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-75109-2 · Cited by 15
A Ketogenic Diet Followed by Gradual Carbohydrate Reintroduction Restores Menstrual Cycles in Women with Polycystic Ovary Syndrome with Oligomenorrhea Independent of Body Weight Loss: Results from a Single-Center, One-Arm, Pilot Study
Rossetti, R., Strinati, V., Caputi, A., Risi, R., Spizzichini, M. L., Mondo, A., Spiniello, L., Lubrano, C., Giancotti, A., Tuccinardi, D., et al. (2024) · Metabolites · doi:10.3390/metabo14120691 · Cited by 17
Identification of the core ontologies and signature genes of polycystic ovary syndrome (PCOS): A bioinformatics analysis
Islam, M. R., Ahmed, M. L., Paul, B. K., Bhuiyan, T., Ahmed, K., & Moni, M. A. (2020) · Informatics in Medicine Unlocked · doi:10.1016/j.imu.2020.100304 · Cited by 14
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome
Çelik, E., Türkçüoğlu, İ., Ata, B., Karaer, A., Kirici, P., Eraslan, S., Taşkapan, Ç., & Berker, B. (2016) · Journal of the Turkish-German Gynecological Association · doi:10.5152/jtgga.2016.16133 · Cited by 14
Anormalidades metabólicas em mulheres com síndrome dos ovários policísticos: obesas e não obesas
Romano, L. G. M., Bedoschi, G., de Melo, A. S., de Albuquerque, F. O., Silva, A. C. J. D. S. R. E., Ferriani, R. A., & Navarro, P. A. (2011) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032011000600008 · Cited by 14
Comparison of a progestin-primed ovarian stimulation protocol with a flexible GnRH antagonist protocol in patients with polycystic ovary syndrome who are participating in an IVF programme: study protocol for a randomised controlled trial
Wang, N., Zhu, Q., Ma, M., Zhou, L., Tao, Y., Wang, Y., & Kuang, Y. (2020) · BMJ Open · doi:10.1136/bmjopen-2020-038153 · Cited by 14
Frequência e fatores de risco para síndrome metabólica em mulheres adolescentes e adultas com síndrome dos ovários policísticos
Pedroso, D. C. C., de Melo, A. S., Carolo, A. L., Vieira, C. S., Silva, A. C. J. D. S. R. E., & dos Reis, R. M. (2012) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032012000800003 · Cited by 14
Genetic Variation in the Mcp-1 Gene Promoter Associated with the Risk of Polycystic Ovary Syndrome
Li, L., Ryoo, J. E., Lee, K.-J., Choi, B. C., & Baek, K. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123045 · Cited by 13
The relationship of soluble neuropilin-1 to severe COVID-19 risk factors in polycystic ovary syndrome
Moin, A. S. M., Sathyapalan, T., Atkin, S. L., & Butler, A. E. (2021) · Metabolism Open · doi:10.1016/j.metop.2021.100079 · Cited by 13
Three-Dimensional Genome Interactions Identify Potential Adipocyte Metabolism-Associated Gene STON1 and Immune-Correlated Gene FSHR at the rs13405728 Locus in Polycystic Ovary Syndrome
Cao, C., Ye, W., Liu, R., Lin, X., Luo, J., Zhang, Q., Lin, S., Geng, L., Ye, S.-K., Shi, Y., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.686054 · Cited by 13
Metabolic Syndrome and Its Characteristics among Reproductive-Aged Women with Polycystic Ovary Syndrome: A Cross-sectional Study in Northwest Iran.
Tabrizi, F. P. F., Alipoor, B., Sadaghiani, M. M., Ostadrahimi, A., & Mahdavi, A. M. (2013) · Europe PMC (PubMed Central) · Cited by 12
Endocrine characteristics, body mass index and metabolic syndrome in women with polycystic ovary syndrome
Li, J., Wu, Q., Wang, C. C., Wang, R., Ng, E. H. Y., Liu, J., Mol, B. W., Wu, X.-K., & Li, W. (2019) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2019.06.014 · Cited by 12
Polycystic ovarian syndrome: a misnomer for an enigmatic disease
Lam, P. M., & Raine‐Fenning, N. J. (2009) · Ultrasound in Obstetrics and Gynecology · doi:10.1002/uog.6414 · Cited by 12

Authors: Moran, L., & Teede, H.
Affiliations: Jean Hailes (AU)
Corresponding author: Moran, Lisa
ORCID: Moran, Lisa
Teede, Helena
Venue: Human Reproduction Update
Publisher: Oxford University Press (OUP)
Published: 2009
Volume: 15
Issue: 4
Pages: 477-488
ISSN: 1355-4786 (ISSN-L)
1460-2369
DOI: 10.1093/humupd/dmp008
OpenAlex: W2102318195
Cited by: 362
References: 113
Citations by year: 2026: 10 · 2025: 15 · 2024: 11 · 2023: 20 · 2022: 18 · 2021: 28 · 2020: 23 · 2019: 19 · 2018: 21 · 2017: 18 · 2016: 25 · 2015: 23 · 2014: 25 · 2013: 30 · 2012: 21
FWCI: 3.58
Type: journal article
Language: en
Open access: closed
Locations: Human Reproduction Update (publishedVersion)
PubMed (publishedVersion)
Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
Keywords: polycystic ovary syndrome, PCOS diagnostic criteria, metabolic abnormalities, insulin resistance, abdominal obesity, type 2 diabetes risk, cardiovascular risk
MeSH terms: Cardiovascular Diseases, Diabetes Mellitus, Type 2, Female, Humans, Insulin Resistance, Phenotype, Polycystic Ovary Syndrome, Risk Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Metabolic features of the reproductive phenotypes of polycystic ovary syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks